NO20073033L - Cytotoksiske midler innbefattende nye taksaner - Google Patents

Cytotoksiske midler innbefattende nye taksaner

Info

Publication number
NO20073033L
NO20073033L NO20073033A NO20073033A NO20073033L NO 20073033 L NO20073033 L NO 20073033L NO 20073033 A NO20073033 A NO 20073033A NO 20073033 A NO20073033 A NO 20073033A NO 20073033 L NO20073033 L NO 20073033L
Authority
NO
Norway
Prior art keywords
cytotoxic agents
taxanes
agents including
including new
new taxanes
Prior art date
Application number
NO20073033A
Other languages
English (en)
Inventor
Alain Commercon
Michael Miller
Ravi V J Chari
Erkan Baloglu
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34931583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073033(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20073033L publication Critical patent/NO20073033L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det er beskrevet nye cytotoksiske midler og deres terapeutiske anvendelse. Nærmere bestemt er det beskrevet nye cytotoksiske midler omfattende taksaner og deres terapeutiske anvendelse. Disse nye cytotoksiske midlene har terapeutisk anvendelse som et resultat av avlevering av taksanene til en spesifikk cellepopulasjon på en målrettet måte ved kjemisk binding av taksanet til et cellebindende middel.
NO20073033A 2004-12-07 2007-06-14 Cytotoksiske midler innbefattende nye taksaner NO20073033L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04292898A EP1669358A1 (en) 2004-12-07 2004-12-07 Cytotoxic agents comprising new taxanes
PCT/EP2005/014177 WO2006061258A2 (en) 2004-12-07 2005-12-02 Cytotoxic agents comprising new taxanes

Publications (1)

Publication Number Publication Date
NO20073033L true NO20073033L (no) 2007-08-28

Family

ID=34931583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073033A NO20073033L (no) 2004-12-07 2007-06-14 Cytotoksiske midler innbefattende nye taksaner

Country Status (22)

Country Link
US (1) US7667054B2 (no)
EP (2) EP1669358A1 (no)
JP (1) JP2008523019A (no)
KR (1) KR20070085781A (no)
CN (1) CN101094857A (no)
AR (1) AR054100A1 (no)
AU (1) AU2005313444B2 (no)
BR (1) BRPI0518869A2 (no)
CA (1) CA2588587A1 (no)
DO (1) DOP2005000248A (no)
EA (1) EA012625B1 (no)
IL (1) IL183404A0 (no)
MA (1) MA29103B1 (no)
MX (1) MX2007006765A (no)
MY (1) MY144632A (no)
NO (1) NO20073033L (no)
NZ (1) NZ555406A (no)
PE (2) PE20110001A1 (no)
TW (1) TW200637836A (no)
UY (1) UY29249A1 (no)
WO (1) WO2006061258A2 (no)
ZA (1) ZA200704790B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446317T1 (de) 2001-05-11 2009-11-15 Ludwig Inst For Cancer Res Ltd Spezifische bindungsproteine und ihre verwendung
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
JP5276017B2 (ja) * 2007-01-25 2013-08-28 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｅｇｆｒ変異体仲介性疾患の治療における抗ｅｇｆｒ抗体の使用
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
CN101688229B (zh) * 2007-03-15 2013-06-12 路德维格癌症研究所 包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途
CN101896503B (zh) 2007-08-14 2018-05-22 路德维格癌症研究所有限公司 靶向egf受体的单克隆抗体175及其衍生物和用途
FR2947269B1 (fr) 2009-06-29 2013-01-18 Sanofi Aventis Nouveaux composes anticancereux
FR2949469A1 (fr) 2009-08-25 2011-03-04 Sanofi Aventis Derives anticancereux, leur preparation et leur application en therapeutique
US20110076232A1 (en) * 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
TW201117814A (en) 2009-10-02 2011-06-01 Sanofi Aventis New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
CN101851231A (zh) * 2010-05-27 2010-10-06 东北林业大学 一种多西紫杉醇新衍生物的合成方法及其在制备抗肿瘤药物中的应用
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique
PL2872157T3 (pl) 2012-07-12 2020-07-13 Hangzhou Dac Biotech Co., Ltd Koniugaty wiążących komórkę cząsteczek ze środkami cytotoksycznymi
ES2701076T3 (es) 2012-11-24 2019-02-20 Hangzhou Dac Biotech Co Ltd Enlazadores hidrofílicos y sus usos para la conjugación de fármacos a las moléculas que se unen a las células
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
CN104693156A (zh) * 2014-10-22 2015-06-10 上海大学 9,10-二羟基-1-去氧紫杉醇类似物及其制备方法
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
US20210308277A1 (en) 2016-11-14 2021-10-07 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703247A (en) * 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
DE60032633T2 (de) * 1999-11-24 2007-10-04 Immunogen Inc., Cambridge Zytotoxische mittel, die taxane enthalten und ihre therapeutische anwendung
US6596757B1 (en) * 2002-05-14 2003-07-22 Immunogen Inc. Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
CA2494074A1 (en) * 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use

Also Published As

Publication number Publication date
AR054100A1 (es) 2007-06-06
AU2005313444B2 (en) 2011-11-10
ZA200704790B (en) 2008-08-27
BRPI0518869A2 (pt) 2008-12-16
EP1669358A1 (en) 2006-06-14
MY144632A (en) 2011-10-14
WO2006061258A2 (en) 2006-06-15
EA200701251A1 (ru) 2007-12-28
PE20110001A1 (es) 2011-01-21
MX2007006765A (es) 2007-08-16
TW200637836A (en) 2006-11-01
AU2005313444A1 (en) 2006-06-15
CA2588587A1 (en) 2006-06-15
UY29249A1 (es) 2006-06-30
DOP2005000248A (es) 2007-02-15
WO2006061258A3 (en) 2006-09-28
KR20070085781A (ko) 2007-08-27
US7667054B2 (en) 2010-02-23
US20060178427A1 (en) 2006-08-10
MA29103B1 (fr) 2007-12-03
PE20061060A1 (es) 2006-11-14
CN101094857A (zh) 2007-12-26
NZ555406A (en) 2011-02-25
EA012625B1 (ru) 2009-10-30
EP1824858A2 (en) 2007-08-29
JP2008523019A (ja) 2008-07-03
IL183404A0 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
NO20073033L (no) Cytotoksiske midler innbefattende nye taksaner
TW200640893A (en) Cytotoxic agents comprising new C-2 modified taxanes
NO20066050L (no) Substituerte indazoler, sammensetninger inneholdende disse samt fremstilling og anvendelse derav
DE602005017753D1 (de) Mittel für die transdermale verabreichung von nikotin
NO20080068L (no) Topisk unguale formuleringer
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
MY157715A (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
CL2008001197A1 (es) Compuestos derivados de amidas sustituidas, moduladoras de la actividad de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo i; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como sindrome metabolico, resistencia a la insulina, dislipidemia, entre otras.
NO20084712L (no) Nye farmasoytiske forbindelser
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA200700717A1 (ru) Сульфонамиды
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
ATE482209T1 (de) Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität
MX2009004883A (es) Piridil sulfoximinas multi-substituidas y su uso como insecticidas.
UY31484A1 (es) Piperidinas heteroaril-sustituidas
NO20090305L (no) Cyklosporin formuleringer
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
UY28731A1 (es) Compuestos quimicos
RS54863B1 (sr) Upotreba sredstva za suzbijanje vlažne truleži i postupak suzbijanja iste
CL2008002185A1 (es) Compuestos derivados de pirimidina, inhibidores de fosfatidilinositol-3-cinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de enfermedades resapiratorias, alergias, inflamacion, cancer, entre otras enfermedades.
CL2008002242A1 (es) Compuestos derivados de n-cicloalquil-n-carboxamida, tiocarboxamida, biciclicas o derivados de carboximidamida n-sustituida; composicion fungicida; y metodo para controlar los hongos fitopatogenos de los cultivos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application